9-year J&J science chief Stoffels to steer Galapagos’ rebound as CEO
9-year J&J science chief Stoffels to steer Galapagos’ rebound as [...]
Septerna emerges with $100M to spark ‘second golden age’ of prolific drug target GPCR with pioneer as co-founder
Septerna emerges with $100M to spark ‘second golden age’ of [...]
Incyte pulls FDA filing for cancer drug approval over confirmatory study, following Gilead out of the exit
Incyte pulls FDA filing for cancer drug approval over confirmatory [...]
Gilead’s $4.9B oncology bet hit with partial clinical hold, forcing pause of pivotal trials and raising doubts about CD47
Gilead’s $4.9B oncology bet hit with partial clinical hold, forcing [...]
Gilead tags along again to support cell therapy biotech Kyverna in $85M fundraising
Gilead tags along again to support cell therapy biotech Kyverna [...]
Pfizer, BioNTech launch trial for potential omicron-busting vaccine
Pfizer, BioNTech launch trial for potential omicron-busting vaccine aarmstrong Tue, [...]
Sierra’s bet on Gilead castoff pays off, teeing up FDA filing for rival to Incyte-Novartis cancer drug
Sierra’s bet on Gilead castoff pays off, teeing up FDA [...]
AstraZeneca success torpedoes PCI’s pivotal plan, crushing stock
AstraZeneca success torpedoes PCI’s pivotal plan, crushing stock ntaylor Tue, [...]
New clinical trial organization launches with promise to conduct randomized trials at fraction of the cost
New clinical trial organization launches with promise to conduct randomized [...]
1b, or not 1b: FDA hits Viking with clinical hold over mix-up in phase of rare disease trial
1b, or not 1b: FDA hits Viking with clinical hold [...]